#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=Romina Mizrahi
1-1	0-6	Romina	person[1]	new[1]	coref	2-1[0_1]
1-2	7-14	Mizrahi	person[1]	new[1]	_	_

#Text=Romina
2-1	15-21	Romina	person	giv	coref	3-1

#Text=Mizrahi
3-1	22-29	Mizrahi	person	giv	coref	7-1[17_0]

#Text=is an Argentine-Canadian
4-1	30-32	is	_	_	_	_
4-2	33-35	an	person[4]	new[4]	_	_
4-3	36-54	Argentine-Canadian	person[4]	new[4]	_	_

#Text=Associate Professor of Psychiatry at the University of Toronto and is a Head of the Focus on Youth Psychosis Prevention Clinic of the Centre for Addiction and Mental Health . [ 1 ]
5-1	55-64	Associate	person[5]	new[5]	coref	5-12[6_5]
5-2	65-74	Professor	person[5]	new[5]	_	_
5-3	75-77	of	person[5]	new[5]	_	_
5-4	78-88	Psychiatry	person[5]	new[5]	_	_
5-5	89-91	at	person[5]	new[5]	_	_
5-6	92-95	the	person[5]	new[5]	_	_
5-7	96-106	University	person[5]	new[5]	_	_
5-8	107-109	of	person[5]	new[5]	_	_
5-9	110-117	Toronto	person[5]	new[5]	_	_
5-10	118-121	and	_	_	_	_
5-11	122-124	is	_	_	_	_
5-12	125-126	a	person[6]	giv[6]	_	_
5-13	127-131	Head	person[6]	giv[6]	_	_
5-14	132-134	of	person[6]	giv[6]	_	_
5-15	135-138	the	person[6]|abstract[7]	giv[6]|new[7]	_	_
5-16	139-144	Focus	person[6]|abstract[7]	giv[6]|new[7]	_	_
5-17	145-147	on	person[6]|abstract[7]	giv[6]|new[7]	_	_
5-18	148-153	Youth	person[6]|abstract[7]|person|abstract[11]	giv[6]|new[7]|new|new[11]	_	_
5-19	154-163	Psychosis	person[6]|abstract[7]|abstract|abstract[11]	giv[6]|new[7]|new|new[11]	coref	16-64
5-20	164-174	Prevention	person[6]|abstract[7]|abstract|abstract[11]	giv[6]|new[7]|new|new[11]	_	_
5-21	175-181	Clinic	person[6]|abstract[7]|abstract[11]	giv[6]|new[7]|new[11]	_	_
5-22	182-184	of	person[6]|abstract[7]|abstract[11]	giv[6]|new[7]|new[11]	_	_
5-23	185-188	the	person[6]|abstract[7]|abstract[11]|abstract[12]	giv[6]|new[7]|new[11]|new[12]	_	_
5-24	189-195	Centre	person[6]|abstract[7]|abstract[11]|abstract[12]	giv[6]|new[7]|new[11]|new[12]	_	_
5-25	196-199	for	person[6]|abstract[7]|abstract[11]	giv[6]|new[7]|new[11]	_	_
5-26	200-209	Addiction	person[6]|abstract[7]|abstract[11]|abstract|abstract[14]	giv[6]|new[7]|new[11]|new|new[14]	coref|coref	11-22[0_14]|11-22[0_14]
5-27	210-213	and	person[6]|abstract[7]|abstract[11]|abstract[14]	giv[6]|new[7]|new[11]|new[14]	_	_
5-28	214-220	Mental	person[6]|abstract[7]|abstract[11]|abstract[14]	giv[6]|new[7]|new[11]|new[14]	_	_
5-29	221-227	Health	person[6]|abstract[7]|abstract[11]|abstract[14]	giv[6]|new[7]|new[11]|new[14]	_	_
5-30	228-229	.	_	_	_	_
5-31	230-231	[	_	_	_	_
5-32	232-233	1	abstract	new	_	_
5-33	234-235	]	_	_	_	_

#Text=Early and personal life
6-1	236-241	Early	abstract[16]	new[16]	_	_
6-2	242-245	and	abstract[16]	new[16]	_	_
6-3	246-254	personal	abstract[16]	new[16]	_	_
6-4	255-259	life	abstract[16]	new[16]	_	_

#Text=Romina Mizrahi had obtained her M.D. degree from the University of Buenos Aires in 1998 and in 2007 got her Ph.D. from the University of Toronto . [ 2 ]
7-1	260-266	Romina	person[17]	giv[17]	ana	7-5[0_17]
7-2	267-274	Mizrahi	person[17]	giv[17]	_	_
7-3	275-278	had	_	_	_	_
7-4	279-287	obtained	_	_	_	_
7-5	288-291	her	person|abstract[20]	giv|new[20]	ana|ana	7-20|7-20
7-6	292-296	M.D.	abstract|abstract[20]	new|new[20]	_	_
7-7	297-303	degree	abstract[20]	new[20]	_	_
7-8	304-308	from	_	_	_	_
7-9	309-312	the	organization[21]	new[21]	_	_
7-10	313-323	University	organization[21]	new[21]	_	_
7-11	324-326	of	organization[21]	new[21]	_	_
7-12	327-333	Buenos	organization[21]|place[22]	new[21]|new[22]	_	_
7-13	334-339	Aires	organization[21]|place[22]	new[21]|new[22]	_	_
7-14	340-342	in	_	_	_	_
7-15	343-347	1998	time	new	_	_
7-16	348-351	and	_	_	_	_
7-17	352-354	in	_	_	_	_
7-18	355-359	2007	time	new	_	_
7-19	360-363	got	_	_	_	_
7-20	364-367	her	person|abstract[26]	giv|new[26]	ana|ana	8-3|8-3
7-21	368-373	Ph.D.	abstract[26]	new[26]	_	_
7-22	374-378	from	_	_	_	_
7-23	379-382	the	organization[27]	new[27]	_	_
7-24	383-393	University	organization[27]	new[27]	_	_
7-25	394-396	of	organization[27]	new[27]	_	_
7-26	397-404	Toronto	organization[27]	new[27]	_	_
7-27	405-406	.	_	_	_	_
7-28	407-408	[	_	_	_	_
7-29	409-410	2	abstract	new	_	_
7-30	411-412	]	_	_	_	_

#Text=In 2008 she and her husband had moved to Canada and had two little girls which are three and nine months respectively . [ 3 ]
8-1	413-415	In	_	_	_	_
8-2	416-420	2008	time	new	_	_
8-3	421-424	she	person	giv	ana	8-5
8-4	425-428	and	_	_	_	_
8-5	429-432	her	person|person[32]	giv|new[32]	coref|coref	10-1[39_0]|10-1[39_0]
8-6	433-440	husband	person[32]	new[32]	_	_
8-7	441-444	had	_	_	_	_
8-8	445-450	moved	_	_	_	_
8-9	451-453	to	_	_	_	_
8-10	454-460	Canada	place	new	coref	12-16
8-11	461-464	and	_	_	_	_
8-12	465-468	had	_	_	_	_
8-13	469-472	two	person[34]	new[34]	_	_
8-14	473-479	little	person[34]	new[34]	_	_
8-15	480-485	girls	person[34]	new[34]	_	_
8-16	486-491	which	_	_	_	_
8-17	492-495	are	_	_	_	_
8-18	496-501	three	quantity	new	_	_
8-19	502-505	and	_	_	_	_
8-20	506-510	nine	time[36]	new[36]	_	_
8-21	511-517	months	time[36]	new[36]	_	_
8-22	518-530	respectively	time[36]	new[36]	_	_
8-23	531-532	.	_	_	_	_
8-24	533-534	[	_	_	_	_
8-25	535-536	3	abstract	new	_	_
8-26	537-538	]	_	_	_	_

#Text=Career
9-1	539-545	Career	abstract	new	_	_

#Text=Dr. Mizrahi is specializing in MRI , PET , phenomenology and pathophysiology and is an active seeker for the cure of schizophrenia .
10-1	546-549	Dr.	person[39]	giv[39]	ana	11-1[0_39]
10-2	550-557	Mizrahi	person[39]	giv[39]	_	_
10-3	558-560	is	_	_	_	_
10-4	561-573	specializing	_	_	_	_
10-5	574-576	in	_	_	_	_
10-6	577-580	MRI	abstract	new	_	_
10-7	581-582	,	_	_	_	_
10-8	583-586	PET	animal	new	_	_
10-9	587-588	,	_	_	_	_
10-10	589-602	phenomenology	abstract	new	_	_
10-11	603-606	and	_	_	_	_
10-12	607-622	pathophysiology	abstract	new	_	_
10-13	623-626	and	_	_	_	_
10-14	627-629	is	_	_	_	_
10-15	630-632	an	person[44]	new[44]	_	_
10-16	633-639	active	person[44]	new[44]	_	_
10-17	640-646	seeker	person[44]	new[44]	_	_
10-18	647-650	for	person[44]	new[44]	_	_
10-19	651-654	the	person[44]|abstract[45]	new[44]|new[45]	_	_
10-20	655-659	cure	person[44]|abstract[45]	new[44]|new[45]	_	_
10-21	660-662	of	person[44]|abstract[45]	new[44]|new[45]	_	_
10-22	663-676	schizophrenia	person[44]|abstract[45]|abstract	new[44]|new[45]|new	coref	15-11[89_0]
10-23	677-678	.	_	_	_	_

#Text=She had received numerous funds from the National Institute of Mental Health , Canadian Institutes of Health Research and Ontario Mental Health Foundation with which she was able to develop a new radioligand F-18 .
11-1	679-682	She	person	giv	ana	11-26
11-2	683-686	had	_	_	_	_
11-3	687-695	received	_	_	_	_
11-4	696-704	numerous	quantity[48]	new[48]	_	_
11-5	705-710	funds	quantity[48]	new[48]	_	_
11-6	711-715	from	quantity[48]	new[48]	_	_
11-7	716-719	the	quantity[48]|organization[49]	new[48]|new[49]	_	_
11-8	720-728	National	quantity[48]|organization[49]	new[48]|new[49]	_	_
11-9	729-738	Institute	quantity[48]|organization[49]	new[48]|new[49]	_	_
11-10	739-741	of	quantity[48]|organization[49]	new[48]|new[49]	_	_
11-11	742-748	Mental	quantity[48]|organization[49]	new[48]|new[49]	_	_
11-12	749-755	Health	quantity[48]|organization[49]	new[48]|new[49]	_	_
11-13	756-757	,	_	_	_	_
11-14	758-766	Canadian	organization[50]	new[50]	_	_
11-15	767-777	Institutes	organization[50]	new[50]	_	_
11-16	778-780	of	organization[50]	new[50]	_	_
11-17	781-787	Health	organization[50]|organization[51]	new[50]|new[51]	coref	12-22[0_51]
11-18	788-796	Research	organization[50]|organization[51]	new[50]|new[51]	_	_
11-19	797-800	and	_	_	_	_
11-20	801-808	Ontario	place|organization[54]	new|new[54]	coref|coref|coref|coref	12-18[68_54]|16-17[103_0]|12-18[68_54]|16-17[103_0]
11-21	809-815	Mental	organization[54]	new[54]	_	_
11-22	816-822	Health	abstract|organization[54]	giv|new[54]	coref	23-45[170_0]
11-23	823-833	Foundation	organization[54]	new[54]	_	_
11-24	834-838	with	_	_	_	_
11-25	839-844	which	_	_	_	_
11-26	845-848	she	person	giv	ana	12-7
11-27	849-852	was	_	_	_	_
11-28	853-857	able	_	_	_	_
11-29	858-860	to	_	_	_	_
11-30	861-868	develop	_	_	_	_
11-31	869-870	a	object[57]	new[57]	ana	12-26[0_57]
11-32	871-874	new	object[57]	new[57]	_	_
11-33	875-886	radioligand	place|object[57]	new|new[57]	_	_
11-34	887-891	F-18	object[57]	new[57]	_	_
11-35	892-893	.	_	_	_	_

#Text=This advancement shed the light for her to continue research with the Alzheimer Society of Canada and the Brain & Behavior Research Foundation to test it on humans . [ 4 ] [ 5 ]
12-1	894-898	This	abstract[58]	new[58]	_	_
12-2	899-910	advancement	abstract[58]	new[58]	_	_
12-3	911-915	shed	_	_	_	_
12-4	916-919	the	abstract[59]	new[59]	_	_
12-5	920-925	light	abstract[59]	new[59]	_	_
12-6	926-929	for	abstract[59]	new[59]	_	_
12-7	930-933	her	abstract[59]|person	new[59]|giv	coref	14-5[76_0]
12-8	934-936	to	_	_	_	_
12-9	937-945	continue	_	_	_	_
12-10	946-954	research	abstract	new	coref	16-5[99_0]
12-11	955-959	with	_	_	_	_
12-12	960-963	the	organization[63]	new[63]	_	_
12-13	964-973	Alzheimer	object|organization[63]	new|new[63]	_	_
12-14	974-981	Society	organization[63]	new[63]	_	_
12-15	982-984	of	organization[63]	new[63]	_	_
12-16	985-991	Canada	organization[63]|place	new[63]|giv	coref	14-20
12-17	992-995	and	_	_	_	_
12-18	996-999	the	organization[68]	giv[68]	_	_
12-19	1000-1005	Brain	object|organization[68]	new|giv[68]	coref	15-5
12-20	1006-1007	&	abstract[66]|organization[68]	new[66]|giv[68]	_	_
12-21	1008-1016	Behavior	abstract[66]|organization[68]	new[66]|giv[68]	_	_
12-22	1017-1025	Research	organization|organization[68]	giv|giv[68]	_	_
12-23	1026-1036	Foundation	organization[68]	giv[68]	_	_
12-24	1037-1039	to	_	_	_	_
12-25	1040-1044	test	_	_	_	_
12-26	1045-1047	it	object	giv	_	_
12-27	1048-1050	on	_	_	_	_
12-28	1051-1057	humans	person	new	_	_
12-29	1058-1059	.	_	_	_	_
12-30	1060-1061	[	_	_	_	_
12-31	1062-1063	4	abstract	new	_	_
12-32	1064-1065	]	_	_	_	_
12-33	1066-1067	[	_	_	_	_
12-34	1068-1069	5	abstract	new	_	_
12-35	1070-1071	]	_	_	_	_

#Text=2015
13-1	1072-1076	2015	time	new	coref	14-2[74_0]

#Text=From 2015 to 2018 Romina Mizrahi had worked along with Tomas Paus and studied more than 1,600 boys from Canada , Britain , France , Germany and Ireland .
14-1	1077-1081	From	_	_	_	_
14-2	1082-1086	2015	time[74]	giv[74]	coref	16-2[0_74]
14-3	1087-1089	to	time[74]	giv[74]	_	_
14-4	1090-1094	2018	time[74]|time	giv[74]|new	coref	24-1
14-5	1095-1101	Romina	person[76]	giv[76]	ana	16-3[0_76]
14-6	1102-1109	Mizrahi	person[76]	giv[76]	_	_
14-7	1110-1113	had	_	_	_	_
14-8	1114-1120	worked	_	_	_	_
14-9	1121-1126	along	_	_	_	_
14-10	1127-1131	with	_	_	_	_
14-11	1132-1137	Tomas	person[77]	new[77]	_	_
14-12	1138-1142	Paus	person[77]	new[77]	_	_
14-13	1143-1146	and	_	_	_	_
14-14	1147-1154	studied	_	_	_	_
14-15	1155-1159	more	person[78]	new[78]	_	_
14-16	1160-1164	than	person[78]	new[78]	_	_
14-17	1165-1170	1,600	person[78]	new[78]	_	_
14-18	1171-1175	boys	person[78]	new[78]	_	_
14-19	1176-1180	from	person[78]	new[78]	_	_
14-20	1181-1187	Canada	person[78]|place	new[78]|giv	_	_
14-21	1188-1189	,	person[78]	new[78]	_	_
14-22	1190-1197	Britain	person[78]|place	new[78]|new	_	_
14-23	1198-1199	,	person[78]	new[78]	_	_
14-24	1200-1206	France	person[78]|place	new[78]|new	_	_
14-25	1207-1208	,	person[78]	new[78]	_	_
14-26	1209-1216	Germany	person[78]|place	new[78]|new	_	_
14-27	1217-1220	and	person[78]	new[78]	_	_
14-28	1221-1228	Ireland	person[78]|place	new[78]|new	_	_
14-29	1229-1230	.	_	_	_	_

#Text=The study looked into brain scans , cannabis history and genetic schizophrenia of the patients and was proven that there is cause-and-effect relationship between cannabis and brain changes . [ 6 ]
15-1	1231-1234	The	event[84]	new[84]	_	_
15-2	1235-1240	study	event[84]	new[84]	_	_
15-3	1241-1247	looked	_	_	_	_
15-4	1248-1252	into	_	_	_	_
15-5	1253-1258	brain	object|object[86]	giv|new[86]	coref|coref	15-27|15-27
15-6	1259-1264	scans	object[86]	new[86]	_	_
15-7	1265-1266	,	_	_	_	_
15-8	1267-1275	cannabis	substance|abstract[88]	new|new[88]	coref|coref	15-25|15-25
15-9	1276-1283	history	abstract[88]	new[88]	_	_
15-10	1284-1287	and	_	_	_	_
15-11	1288-1295	genetic	abstract[89]	giv[89]	_	_
15-12	1296-1309	schizophrenia	abstract[89]	giv[89]	_	_
15-13	1310-1312	of	abstract[89]	giv[89]	_	_
15-14	1313-1316	the	abstract[89]|person[90]	giv[89]|new[90]	coref	31-21[197_90]
15-15	1317-1325	patients	abstract[89]|person[90]	giv[89]|new[90]	_	_
15-16	1326-1329	and	_	_	_	_
15-17	1330-1333	was	_	_	_	_
15-18	1334-1340	proven	_	_	_	_
15-19	1341-1345	that	_	_	_	_
15-20	1346-1351	there	_	_	_	_
15-21	1352-1354	is	_	_	_	_
15-22	1355-1371	cause-and-effect	abstract[91]	new[91]	_	_
15-23	1372-1384	relationship	abstract[91]	new[91]	_	_
15-24	1385-1392	between	abstract[91]	new[91]	_	_
15-25	1393-1401	cannabis	abstract[91]|substance|abstract[93]	new[91]|giv|new[93]	coref|coref|coref|coref	18-10[131_0]|28-7[184_93]|18-10[131_0]|28-7[184_93]
15-26	1402-1405	and	abstract[91]|abstract[93]	new[91]|new[93]	_	_
15-27	1406-1411	brain	abstract[91]|abstract[93]|object|abstract[95]	new[91]|new[93]|giv|new[95]	coref|coref	16-71|16-71
15-28	1412-1419	changes	abstract[91]|abstract[93]|abstract[95]	new[91]|new[93]|new[95]	_	_
15-29	1420-1421	.	_	_	_	_
15-30	1422-1423	[	_	_	_	_
15-31	1424-1425	6	abstract	new	_	_
15-32	1426-1427	]	_	_	_	_

#Text=In 2015 she led a research along with Sinthu Suntharalingam at the Children 's Hospital of Eastern Ontario on teenagers who used marijuana and proved that because it uses endocannabinoid system , [ 7 ] it should n't be used for people under the age of 25 [ 8 ] due to risk of memory loss , eruption of symptoms of schizophrenia and psychosis [ 9 ] and even permanent brain damage . [ 10 ]
16-1	1428-1430	In	_	_	_	_
16-2	1431-1435	2015	time	giv	_	_
16-3	1436-1439	she	person	giv	ana	18-4
16-4	1440-1443	led	_	_	_	_
16-5	1444-1445	a	abstract[99]	giv[99]	_	_
16-6	1446-1454	research	abstract[99]	giv[99]	_	_
16-7	1455-1460	along	_	_	_	_
16-8	1461-1465	with	_	_	_	_
16-9	1466-1472	Sinthu	person[100]	new[100]	_	_
16-10	1473-1487	Suntharalingam	person[100]	new[100]	_	_
16-11	1488-1490	at	_	_	_	_
16-12	1491-1494	the	place[102]	new[102]	_	_
16-13	1495-1503	Children	person[101]|place[102]	new[101]|new[102]	_	_
16-14	1504-1506	's	person[101]|place[102]	new[101]|new[102]	_	_
16-15	1507-1515	Hospital	place[102]	new[102]	_	_
16-16	1516-1518	of	place[102]	new[102]	_	_
16-17	1519-1526	Eastern	place[102]|place[103]	new[102]|giv[103]	ana	16-28[0_103]
16-18	1527-1534	Ontario	place[102]|place[103]	new[102]|giv[103]	_	_
16-19	1535-1537	on	place[102]	new[102]	_	_
16-20	1538-1547	teenagers	place[102]|person	new[102]|new	_	_
16-21	1548-1551	who	_	_	_	_
16-22	1552-1556	used	_	_	_	_
16-23	1557-1566	marijuana	substance	new	_	_
16-24	1567-1570	and	_	_	_	_
16-25	1571-1577	proved	_	_	_	_
16-26	1578-1582	that	_	_	_	_
16-27	1583-1590	because	_	_	_	_
16-28	1591-1593	it	place	giv	ana	16-36
16-29	1594-1598	uses	_	_	_	_
16-30	1599-1614	endocannabinoid	object|abstract[108]	new|new[108]	coref|coref	31-18[0_108]|31-18[0_108]
16-31	1615-1621	system	abstract[108]	new[108]	_	_
16-32	1622-1623	,	_	_	_	_
16-33	1624-1625	[	_	_	_	_
16-34	1626-1627	7	abstract	new	_	_
16-35	1628-1629	]	_	_	_	_
16-36	1630-1632	it	place	giv	_	_
16-37	1633-1639	should	_	_	_	_
16-38	1640-1643	n't	_	_	_	_
16-39	1644-1646	be	_	_	_	_
16-40	1647-1651	used	_	_	_	_
16-41	1652-1655	for	_	_	_	_
16-42	1656-1662	people	person	new	_	_
16-43	1663-1668	under	_	_	_	_
16-44	1669-1672	the	abstract[112]	new[112]	_	_
16-45	1673-1676	age	abstract[112]	new[112]	_	_
16-46	1677-1679	of	abstract[112]	new[112]	_	_
16-47	1680-1682	25	abstract[112]|quantity	new[112]|new	_	_
16-48	1683-1684	[	_	_	_	_
16-49	1685-1686	8	quantity	new	_	_
16-50	1687-1688	]	_	_	_	_
16-51	1689-1692	due	abstract[115]	new[115]	coref	35-9[219_115]
16-52	1693-1695	to	abstract[115]	new[115]	_	_
16-53	1696-1700	risk	abstract[115]	new[115]	_	_
16-54	1701-1703	of	abstract[115]	new[115]	_	_
16-55	1704-1710	memory	abstract[115]|abstract|abstract[117]	new[115]|new|new[117]	_	_
16-56	1711-1715	loss	abstract[115]|abstract[117]	new[115]|new[117]	_	_
16-57	1716-1717	,	abstract[115]	new[115]	_	_
16-58	1718-1726	eruption	abstract[115]|abstract[118]	new[115]|new[118]	_	_
16-59	1727-1729	of	abstract[115]|abstract[118]	new[115]|new[118]	_	_
16-60	1730-1738	symptoms	abstract[115]|abstract[118]|abstract[119]	new[115]|new[118]|new[119]	_	_
16-61	1739-1741	of	abstract[115]|abstract[118]|abstract[119]	new[115]|new[118]|new[119]	_	_
16-62	1742-1755	schizophrenia	abstract[115]|abstract[118]|abstract[119]|abstract	new[115]|new[118]|new[119]|new	coref	22-10
16-63	1756-1759	and	abstract[115]|abstract[118]|abstract[119]	new[115]|new[118]|new[119]	_	_
16-64	1760-1769	psychosis	abstract[115]|abstract[118]|abstract[119]|abstract	new[115]|new[118]|new[119]|giv	coref	18-23
16-65	1770-1771	[	abstract[115]	new[115]	_	_
16-66	1772-1773	9	abstract[115]|quantity	new[115]|new	_	_
16-67	1774-1775	]	abstract[115]	new[115]	_	_
16-68	1776-1779	and	abstract[115]	new[115]	_	_
16-69	1780-1784	even	abstract[115]|abstract[124]	new[115]|new[124]	_	_
16-70	1785-1794	permanent	abstract[115]|abstract[124]	new[115]|new[124]	_	_
16-71	1795-1800	brain	abstract[115]|object|abstract[124]	new[115]|giv|new[124]	_	_
16-72	1801-1807	damage	abstract[115]|abstract[124]	new[115]|new[124]	_	_
16-73	1808-1809	.	_	_	_	_
16-74	1810-1811	[	_	_	_	_
16-75	1812-1814	10	abstract	new	_	_
16-76	1815-1816	]	_	_	_	_

#Text=2016
17-1	1817-1821	2016	time	new	coref	18-3

#Text=In June 2016 she and Cory Gerritsen had studied cannabis ' ingredients ; cannabidiol and tetrahydrocannabinol and proved that the latter causes psychosis in adolescents . [ 11 ]
18-1	1822-1824	In	_	_	_	_
18-2	1825-1829	June	time[127]	new[127]	_	_
18-3	1830-1834	2016	time[127]|time	new[127]|giv	_	_
18-4	1835-1838	she	person	giv	coref	19-7[140_0]
18-5	1839-1842	and	_	_	_	_
18-6	1843-1847	Cory	person[130]	new[130]	_	_
18-7	1848-1857	Gerritsen	person[130]	new[130]	_	_
18-8	1858-1861	had	_	_	_	_
18-9	1862-1869	studied	_	_	_	_
18-10	1870-1878	cannabis	substance[131]|substance[132]	giv[131]|new[132]	coref|coref	19-31[0_131]|19-31[0_131]
18-11	1879-1880	'	substance[131]|substance[132]	giv[131]|new[132]	_	_
18-12	1881-1892	ingredients	substance[132]	new[132]	_	_
18-13	1893-1894	;	_	_	_	_
18-14	1895-1906	cannabidiol	substance	new	_	_
18-15	1907-1910	and	_	_	_	_
18-16	1911-1931	tetrahydrocannabinol	substance	new	_	_
18-17	1932-1935	and	_	_	_	_
18-18	1936-1942	proved	_	_	_	_
18-19	1943-1947	that	_	_	_	_
18-20	1948-1951	the	_	_	_	_
18-21	1952-1958	latter	_	_	_	_
18-22	1959-1965	causes	_	_	_	_
18-23	1966-1975	psychosis	abstract	giv	coref	22-27
18-24	1976-1978	in	_	_	_	_
18-25	1979-1990	adolescents	person	new	_	_
18-26	1991-1992	.	_	_	_	_
18-27	1993-1994	[	_	_	_	_
18-28	1995-1997	11	abstract	new	_	_
18-29	1998-1999	]	_	_	_	_

#Text=On November of the same year Dr. Mizrahi worked with Dr. Bill MacEwan on a case of a 21-year old who killed a 13-year old tween while being influenced by cannabis . [ 12 ]
19-1	2000-2002	On	_	_	_	_
19-2	2003-2011	November	time[138]	new[138]	_	_
19-3	2012-2014	of	time[138]	new[138]	_	_
19-4	2015-2018	the	time[138]|time[139]	new[138]|new[139]	coref	23-4[160_139]
19-5	2019-2023	same	time[138]|time[139]	new[138]|new[139]	_	_
19-6	2024-2028	year	time[138]|time[139]	new[138]|new[139]	_	_
19-7	2029-2032	Dr.	person[140]	giv[140]	coref	19-11[141_140]
19-8	2033-2040	Mizrahi	person[140]	giv[140]	_	_
19-9	2041-2047	worked	abstract	new	coref|none	32-16[207_0]|19-9[0_207]
19-10	2048-2052	with	_	_	_	_
19-11	2053-2056	Dr.	person[141]	giv[141]	coref	22-1[0_141]
19-12	2057-2061	Bill	person[141]	giv[141]	_	_
19-13	2062-2069	MacEwan	person[141]	giv[141]	_	_
19-14	2070-2072	on	_	_	_	_
19-15	2073-2074	a	abstract[142]	new[142]	_	_
19-16	2075-2079	case	abstract[142]	new[142]	_	_
19-17	2080-2082	of	abstract[142]	new[142]	_	_
19-18	2083-2084	a	abstract[142]	new[142]	_	_
19-19	2085-2092	21-year	abstract[142]	new[142]	_	_
19-20	2093-2096	old	abstract[142]	new[142]	_	_
19-21	2097-2100	who	_	_	_	_
19-22	2101-2107	killed	_	_	_	_
19-23	2108-2109	a	person[143]	new[143]	_	_
19-24	2110-2117	13-year	person[143]	new[143]	_	_
19-25	2118-2121	old	person[143]	new[143]	_	_
19-26	2122-2127	tween	person[143]	new[143]	_	_
19-27	2128-2133	while	_	_	_	_
19-28	2134-2139	being	_	_	_	_
19-29	2140-2150	influenced	_	_	_	_
19-30	2151-2153	by	_	_	_	_
19-31	2154-2162	cannabis	substance	giv	coref	23-32
19-32	2163-2164	.	_	_	_	_
19-33	2165-2166	[	_	_	_	_
19-34	2167-2169	12	abstract	new	_	_
19-35	2170-2171	]	_	_	_	_

#Text=2017
20-1	2172-2176	2017	time	new	coref	21-3

#Text=In January 2017
21-1	2177-2179	In	_	_	_	_
21-2	2180-2187	January	time[147]	new[147]	_	_
21-3	2188-2192	2017	time[147]|time	new[147]|giv	_	_

#Text=Mizrahi had studied Canadian immigrants for the symptoms of schizophrenia which was caused by dopamine [ 13 ] and established a possible link between migration and psychosis . [ 14 ]
22-1	2193-2200	Mizrahi	person	giv	ana	23-7
22-2	2201-2204	had	_	_	_	_
22-3	2205-2212	studied	_	_	_	_
22-4	2213-2221	Canadian	person[150]	new[150]	_	_
22-5	2222-2232	immigrants	person[150]	new[150]	_	_
22-6	2233-2236	for	person[150]	new[150]	_	_
22-7	2237-2240	the	person[150]|abstract[151]	new[150]|new[151]	coref	28-18[186_151]
22-8	2241-2249	symptoms	person[150]|abstract[151]	new[150]|new[151]	_	_
22-9	2250-2252	of	person[150]|abstract[151]	new[150]|new[151]	_	_
22-10	2253-2266	schizophrenia	person[150]|abstract[151]|abstract	new[150]|new[151]|giv	_	_
22-11	2267-2272	which	_	_	_	_
22-12	2273-2276	was	_	_	_	_
22-13	2277-2283	caused	_	_	_	_
22-14	2284-2286	by	_	_	_	_
22-15	2287-2295	dopamine	substance	new	_	_
22-16	2296-2297	[	_	_	_	_
22-17	2298-2300	13	abstract	new	_	_
22-18	2301-2302	]	_	_	_	_
22-19	2303-2306	and	_	_	_	_
22-20	2307-2318	established	_	_	_	_
22-21	2319-2320	a	abstract[155]	new[155]	coref	28-3[182_155]
22-22	2321-2329	possible	abstract[155]	new[155]	_	_
22-23	2330-2334	link	abstract[155]	new[155]	_	_
22-24	2335-2342	between	abstract[155]	new[155]	_	_
22-25	2343-2352	migration	abstract[155]|abstract	new[155]|new	_	_
22-26	2353-2356	and	abstract[155]	new[155]	_	_
22-27	2357-2366	psychosis	abstract[155]|abstract	new[155]|giv	coref	35-7
22-28	2367-2368	.	_	_	_	_
22-29	2369-2370	[	_	_	_	_
22-30	2371-2373	14	abstract	new	_	_
22-31	2374-2375	]	_	_	_	_

#Text=In May of the same year she had partnered with Diane Kelsall who was a chief editor of the Canadian Medical Association Journal to push for a stricter guidelines in the Cannabis Act , which were approved later on by the Canadian Minister of Health Jane Philpott . [ 15 ]
23-1	2376-2378	In	_	_	_	_
23-2	2379-2382	May	time[159]	new[159]	_	_
23-3	2383-2385	of	time[159]	new[159]	_	_
23-4	2386-2389	the	time[159]|time[160]	new[159]|giv[160]	_	_
23-5	2390-2394	same	time[159]|time[160]	new[159]|giv[160]	_	_
23-6	2395-2399	year	time[159]|time[160]	new[159]|giv[160]	_	_
23-7	2400-2403	she	person	giv	coref	31-1[190_0]
23-8	2404-2407	had	_	_	_	_
23-9	2408-2417	partnered	_	_	_	_
23-10	2418-2422	with	_	_	_	_
23-11	2423-2428	Diane	person[162]	new[162]	ana	25-11[0_162]
23-12	2429-2436	Kelsall	person[162]	new[162]	_	_
23-13	2437-2440	who	_	_	_	_
23-14	2441-2444	was	_	_	_	_
23-15	2445-2446	a	person[163]	new[163]	_	_
23-16	2447-2452	chief	person[163]	new[163]	_	_
23-17	2453-2459	editor	person[163]	new[163]	_	_
23-18	2460-2462	of	person[163]	new[163]	_	_
23-19	2463-2466	the	person[163]|organization[165]	new[163]|new[165]	coref	32-21[209_165]
23-20	2467-2475	Canadian	person[163]|organization[165]	new[163]|new[165]	_	_
23-21	2476-2483	Medical	person[163]|organization[165]	new[163]|new[165]	_	_
23-22	2484-2495	Association	person[163]|organization|organization[165]	new[163]|new|new[165]	_	_
23-23	2496-2503	Journal	person[163]|organization[165]	new[163]|new[165]	_	_
23-24	2504-2506	to	_	_	_	_
23-25	2507-2511	push	_	_	_	_
23-26	2512-2515	for	_	_	_	_
23-27	2516-2517	a	abstract[166]	new[166]	_	_
23-28	2518-2526	stricter	abstract[166]	new[166]	_	_
23-29	2527-2537	guidelines	abstract[166]	new[166]	_	_
23-30	2538-2540	in	abstract[166]	new[166]	_	_
23-31	2541-2544	the	abstract[166]|abstract[168]	new[166]|new[168]	_	_
23-32	2545-2553	Cannabis	abstract[166]|person|abstract[168]	new[166]|giv|new[168]	coref	26-1
23-33	2554-2557	Act	abstract[166]|abstract[168]	new[166]|new[168]	_	_
23-34	2558-2559	,	_	_	_	_
23-35	2560-2565	which	_	_	_	_
23-36	2566-2570	were	_	_	_	_
23-37	2571-2579	approved	_	_	_	_
23-38	2580-2585	later	_	_	_	_
23-39	2586-2588	on	_	_	_	_
23-40	2589-2591	by	_	_	_	_
23-41	2592-2595	the	person[169]	new[169]	_	_
23-42	2596-2604	Canadian	person[169]	new[169]	_	_
23-43	2605-2613	Minister	person[169]	new[169]	_	_
23-44	2614-2616	of	person[169]	new[169]	_	_
23-45	2617-2623	Health	person[169]|abstract[170]	new[169]|giv[170]	_	_
23-46	2624-2628	Jane	person[169]|abstract[170]	new[169]|giv[170]	_	_
23-47	2629-2637	Philpott	person[169]|abstract[170]	new[169]|giv[170]	_	_
23-48	2638-2639	.	_	_	_	_
23-49	2640-2641	[	_	_	_	_
23-50	2642-2644	15	abstract	new	_	_
23-51	2645-2646	]	_	_	_	_

#Text=2018
24-1	2647-2651	2018	time	giv	coref	25-3

#Text=In May 2018 , in an interview with Leafly , she told the site that
25-1	2652-2654	In	_	_	_	_
25-2	2655-2658	May	time[173]	new[173]	_	_
25-3	2659-2663	2018	time[173]|time	new[173]|giv	coref	30-2[189_0]
25-4	2664-2665	,	_	_	_	_
25-5	2666-2668	in	_	_	_	_
25-6	2669-2671	an	event[175]	new[175]	_	_
25-7	2672-2681	interview	event[175]	new[175]	_	_
25-8	2682-2686	with	event[175]	new[175]	_	_
25-9	2687-2693	Leafly	event[175]|organization	new[175]|new	_	_
25-10	2694-2695	,	_	_	_	_
25-11	2696-2699	she	person	giv	_	_
25-12	2700-2704	told	_	_	_	_
25-13	2705-2708	the	organization[178]	new[178]	_	_
25-14	2709-2713	site	organization[178]	new[178]	_	_
25-15	2714-2718	that	_	_	_	_

#Text=Cannabis could be a trigger of an underlying condition .
26-1	2719-2727	Cannabis	abstract	giv	coref	26-4[180_0]
26-2	2728-2733	could	_	_	_	_
26-3	2734-2736	be	_	_	_	_
26-4	2737-2738	a	abstract[180]	giv[180]	coref	28-7[0_180]
26-5	2739-2746	trigger	abstract[180]	giv[180]	_	_
26-6	2747-2749	of	abstract[180]	giv[180]	_	_
26-7	2750-2752	an	abstract[180]|abstract[181]	giv[180]|new[181]	_	_
26-8	2753-2763	underlying	abstract[180]|abstract[181]	giv[180]|new[181]	_	_
26-9	2764-2773	condition	abstract[180]|abstract[181]	giv[180]|new[181]	_	_
26-10	2774-2775	.	_	_	_	_

#Text=and that
27-1	2776-2779	and	_	_	_	_
27-2	2780-2784	that	_	_	_	_

#Text=There is a proven link between cannabis and psychotic experience , [ but ] who will experience those symptoms or when [ remains unclear ] .
28-1	2785-2790	There	_	_	_	_
28-2	2791-2793	is	_	_	_	_
28-3	2794-2795	a	abstract[182]	giv[182]	_	_
28-4	2796-2802	proven	abstract[182]	giv[182]	_	_
28-5	2803-2807	link	abstract[182]	giv[182]	_	_
28-6	2808-2815	between	abstract[182]	giv[182]	_	_
28-7	2816-2824	cannabis	abstract[182]|substance|abstract[184]	giv[182]|giv|giv[184]	coref|coref	32-19|32-19
28-8	2825-2828	and	abstract[182]|abstract[184]	giv[182]|giv[184]	_	_
28-9	2829-2838	psychotic	abstract[182]|abstract[184]|abstract[185]	giv[182]|giv[184]|new[185]	_	_
28-10	2839-2849	experience	abstract[182]|abstract[184]|abstract[185]	giv[182]|giv[184]|new[185]	_	_
28-11	2850-2851	,	_	_	_	_
28-12	2852-2853	[	_	_	_	_
28-13	2854-2857	but	_	_	_	_
28-14	2858-2859	]	_	_	_	_
28-15	2860-2863	who	_	_	_	_
28-16	2864-2868	will	_	_	_	_
28-17	2869-2879	experience	_	_	_	_
28-18	2880-2885	those	abstract[186]	giv[186]	_	_
28-19	2886-2894	symptoms	abstract[186]	giv[186]	_	_
28-20	2895-2897	or	_	_	_	_
28-21	2898-2902	when	_	_	_	_
28-22	2903-2904	[	_	_	_	_
28-23	2905-2912	remains	_	_	_	_
28-24	2913-2920	unclear	_	_	_	_
28-25	2921-2922	]	_	_	_	_
28-26	2923-2924	.	_	_	_	_

#Text=[ 16 ]
29-1	2925-2926	[	_	_	_	_
29-2	2927-2929	16	abstract	new	_	_
29-3	2930-2931	]	_	_	_	_

#Text=In July 2018
30-1	2932-2934	In	_	_	_	_
30-2	2935-2939	July	time|time[189]	new|giv[189]	coref|coref	32-3[0_189]|32-3[0_189]
30-3	2940-2944	2018	time[189]	giv[189]	_	_

#Text=Romina Mizrahi had suggested that cortisol , the main stress hormone , is responsible for stress regulatory system failures with schizophrenic patients by studying their striatum . [ 17 ]
31-1	2945-2951	Romina	person[190]	giv[190]	coref	32-4[203_190]
31-2	2952-2959	Mizrahi	person[190]	giv[190]	_	_
31-3	2960-2963	had	_	_	_	_
31-4	2964-2973	suggested	_	_	_	_
31-5	2974-2978	that	substance[191]	new[191]	appos	31-8[193_191]
31-6	2979-2987	cortisol	substance[191]	new[191]	_	_
31-7	2988-2989	,	_	_	_	_
31-8	2990-2993	the	substance[193]	giv[193]	_	_
31-9	2994-2998	main	substance[193]	giv[193]	_	_
31-10	2999-3005	stress	abstract|substance[193]	new|giv[193]	coref	31-16
31-11	3006-3013	hormone	substance[193]	giv[193]	_	_
31-12	3014-3015	,	_	_	_	_
31-13	3016-3018	is	_	_	_	_
31-14	3019-3030	responsible	_	_	_	_
31-15	3031-3034	for	_	_	_	_
31-16	3035-3041	stress	abstract	giv	_	_
31-17	3042-3052	regulatory	event[196]	new[196]	_	_
31-18	3053-3059	system	abstract|event[196]	giv|new[196]	_	_
31-19	3060-3068	failures	event[196]	new[196]	_	_
31-20	3069-3073	with	event[196]	new[196]	_	_
31-21	3074-3087	schizophrenic	event[196]|person[197]	new[196]|giv[197]	ana	31-25[0_197]
31-22	3088-3096	patients	event[196]|person[197]	new[196]|giv[197]	_	_
31-23	3097-3099	by	_	_	_	_
31-24	3100-3108	studying	_	_	_	_
31-25	3109-3114	their	person|object[199]	giv|new[199]	ana|ana	32-16|32-16
31-26	3115-3123	striatum	object[199]	new[199]	_	_
31-27	3124-3125	.	_	_	_	_
31-28	3126-3127	[	_	_	_	_
31-29	3128-3130	17	abstract	new	_	_
31-30	3131-3132	]	_	_	_	_

#Text=In October 2018 Dr. Mizrahi partnered with Randi Schuster of Massachusetts General Hospital and published their work on cannabis in The Journal of Clinical Psychiatry . [ 18 ]
32-1	3133-3135	In	_	_	_	_
32-2	3136-3143	October	time[201]	new[201]	_	_
32-3	3144-3148	2018	time[201]|time	new[201]|giv	coref	34-1
32-4	3149-3152	Dr.	person[203]	giv[203]	coref	35-12[220_203]
32-5	3153-3160	Mizrahi	person[203]	giv[203]	_	_
32-6	3161-3170	partnered	_	_	_	_
32-7	3171-3175	with	_	_	_	_
32-8	3176-3181	Randi	person[204]	new[204]	_	_
32-9	3182-3190	Schuster	person[204]	new[204]	_	_
32-10	3191-3193	of	person[204]	new[204]	_	_
32-11	3194-3207	Massachusetts	person[204]|place	new[204]|new	_	_
32-12	3208-3215	General	person[204]	new[204]	_	_
32-13	3216-3224	Hospital	person[204]	new[204]	_	_
32-14	3225-3228	and	_	_	_	_
32-15	3229-3238	published	_	_	_	_
32-16	3239-3244	their	person|abstract[207]	giv|new[207]	_	_
32-17	3245-3249	work	abstract[207]	new[207]	_	_
32-18	3250-3252	on	_	_	_	_
32-19	3253-3261	cannabis	substance	giv	_	_
32-20	3262-3264	in	_	_	_	_
32-21	3265-3268	The	organization[209]	giv[209]	_	_
32-22	3269-3276	Journal	organization[209]	giv[209]	_	_
32-23	3277-3279	of	organization[209]	giv[209]	_	_
32-24	3280-3288	Clinical	organization[209]|abstract[210]	giv[209]|new[210]	_	_
32-25	3289-3299	Psychiatry	organization[209]|abstract[210]	giv[209]|new[210]	_	_
32-26	3300-3301	.	_	_	_	_
32-27	3302-3303	[	_	_	_	_
32-28	3304-3306	18	abstract	new	_	_
32-29	3307-3308	]	_	_	_	_

#Text=Works
33-1	3309-3314	Works	person	new	_	_

#Text=2018 -
34-1	3315-3319	2018	time	giv	_	_
34-2	3320-3321	-	_	_	_	_

#Text=Molecular imaging studies in youth with psychosis and psychosis risk with Dr Romina Mizrahi
35-1	3322-3331	Molecular	event[215]	new[215]	_	_
35-2	3332-3339	imaging	abstract|event[215]	new|new[215]	_	_
35-3	3340-3347	studies	event[215]	new[215]	_	_
35-4	3348-3350	in	event[215]	new[215]	_	_
35-5	3351-3356	youth	event[215]|person[216]	new[215]|new[216]	_	_
35-6	3357-3361	with	event[215]|person[216]	new[215]|new[216]	_	_
35-7	3362-3371	psychosis	event[215]|person[216]|abstract	new[215]|new[216]|giv	coref	35-9
35-8	3372-3375	and	_	_	_	_
35-9	3376-3385	psychosis	abstract|abstract[219]	giv|giv[219]	_	_
35-10	3386-3390	risk	abstract[219]	giv[219]	_	_
35-11	3391-3395	with	abstract[219]	giv[219]	_	_
35-12	3396-3398	Dr	abstract[219]|person[220]	giv[219]|giv[220]	_	_
35-13	3399-3405	Romina	abstract[219]|person[220]	giv[219]|giv[220]	_	_
35-14	3406-3413	Mizrahi	abstract[219]|person[220]	giv[219]|giv[220]	_	_

#Text=[ 19 ]
36-1	3414-3415	[	_	_	_	_
36-2	3416-3418	19	abstract	new	_	_
36-3	3419-3420	]	_	_	_	_
